Saltar al contenido
Merck

Saltar a

A1908

Asialofetuin from fetal calf serum

Type II (Sigma designation)

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
Tamaño de envaseSKUDisponibilidadPrecio
50 mg
Comprobar disponibilidad del carrito
MXP 15,684.00

Acerca de este artículo

UNSPSC Code:
12352202
NACRES:
NA.61
MDL number:
Form:
powder
Biological source:
bovine

MXP 15,684.00


Comprobar disponibilidad del carrito

Solicite una orden a granel
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


biological source

bovine

Quality Level

type

Type II (Sigma designation)

form

powder

technique(s)

activity assay: suitable, inhibition assay: suitable

impurities

salt, essentially free, ≤1.0% N-acetylneuraminic acid

solubility

H2O: soluble 1.0 mg/mL, clear to hazy, colorless to very faintly yellow

storage temp.

2-8°C

Application

Asialofetuin from fetal calf serum is suitable for use:
  • in the assay of the lactose binding activity of the galectin-7 by immunodetection of in situ binding activity to asialofetuin immobilized on nitrocellulose[1]
  • in the inhibition of zona pellucida hardening of mouse oocytes[2]
  • as an acceptor in sialyltransferase enzyme activity assay[3]
Incorporation of asialofetuin (AF) in liposomes strongly enhance delivery to and endocytosis by cells displaying the AF receptor, notably hepatocytes. This provides a very efficient route for gene therapy.

Biochem/physiol Actions

Feutins are glycoproteins that belong to the cystatin superfamily. They are characterized by the presence of two tandemly arranged cystatin-like domains and an unrelated domain.[4] It binds to transforming growth factor (TGF)-β/BMP (bone morphogenic protein) cytokines.[5]
Asialofetuin (AF) binds to asialoglycoprotein receptor (ASGP-R) and is employed as a ligand for drug delivery to the hepatocytes. It aids serum-resistant lipoplexes for efficient gene deliver into the HepG2 (human hepatoblastoma) cells.

Preparation Note

Enzymatic cleavage using neuraminidase

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
A4781F2379F3004
technique(s)

activity assay: suitable, inhibition assay: suitable

technique(s)

-

technique(s)

cell culture | mammalian: suitable

technique(s)

HPLC: suitable, MALDI-MS: suitable

biological source

bovine

biological source

bovine (calf) serum

biological source

bovine serum (fetal)

biological source

bovine serum (fetal)

form

powder

form

powder

form

lyophilized powder

form

lyophilized powder

impurities

salt, essentially free, ≤1.0% N-acetylneuraminic acid

impurities

salt, essentially free, ≤0.5% N-acetylneuraminic acid

impurities

≤0.3% free N-acetylneuraminic acid

impurities

~0.2% free N-acetylneuraminic acid

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

solubility

H2O: soluble 1.0 mg/mL, clear to hazy, colorless to very faintly yellow

solubility

0.85% sodium chloride: soluble 1 mg/mL

solubility

H2O: 1 mg/mL, colorless to faint yellow or tan

solubility

-


Still not finding the right product?

Explore all of our products under


Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



In vitro gene delivery mediated by asialofetuin-appended cationic liposomes associated with gamma-cyclodextrin into hepatocytes
Motoyama K, et al.
Journal of Drug Delivery, 2011 (2011)
W M Brown et al.
BioEssays : news and reviews in molecular, cellular and developmental biology, 14(11), 749-755 (1992-11-01)
Bovine fetuin, the first fetal protein to be described, has recently been shown to be a species homologue of a well known human plasma protein--alpha 2HS glycoprotein (alpha 2HS). The fetuins are now known to be members of the cystatin
Serum-resistant lipoplexes in the presence of asialofetuin
Liposomes, 2011, 425-434 (2010)



Número de artículo de comercio global

SKUGTIN
A1908-50MG04061833257890

Questions

  1. What is the difference in Type 1 versus Type II asialofetuin?

    1 answer
    1. The difference between the Type I and Type II Asialofetuin products does not represent any kind of biochemical or functional difference. These indicate different methods of production and purification. The Type II option, product A1908, utilizes neuraminadase in an enzymatic cleavage step. The Type I, product A4781, utilizes a proprietary modification of that described in Spiro, R.G., J. Biol. Chem., 235, 2860 (1960).

      Helpful?

Reviews

No rating value

Active Filters